Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AHA omega-3 statement

This article was originally published in The Tan Sheet

Executive Summary

"Evidence from prospective secondary prevention trials suggests" eicosapentaenoic acid plus docosahexaenoic acid "significantly reduce subsequent cardiac and all-cause mortality," AHA scientific statement in Nov. 19 Circulation says. Penny Kris-Etherton, PhD, et al., suggest while a dietary approach to increase omega-3 fatty acid intake "is preferable," supplements may be considered for those who cannot consume the recommended .5 g/d to 1.8 g/d through fish alone. However, researchers note "additional studies are needed to confirm and further define the health benefits of omega-3 fatty acid supplements for both primary and secondary prevention" of coronary disease. Patients taking more than 3 g of EPA + DHA from supplements "should do so only under a physician's care," Kris-Etherton et al. add...
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS094836

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel